Genmab and PDL Biopharma close sale of antibody manufacturing facility

17-Mar-2008

Genmab A/S and PDL BioPharma, Inc. announced the closing of the previously announced transaction under which Genmab has acquired PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota, USA for USD 240 million in cash. The transaction was first announced on February 21, 2008.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

Last viewed contents